Guidelines Only Up To Pre-Clinical Stage

THE department of biotechnology (DBT) is planning to set up National Biotechnology Regulatory Board to specify and regulate development of drugs and vaccines from natural sources, such as humans, animals or micro-organism, a DBT official said.

The State Cabinet, on Monday, decided to adopt Bio-tech policy-2, which focuses on capacity building, deregulating certain provisions coming in the way of the growth of the sector, providing the much-needed fiscal incentives and concessions and building up the necessary infrastructure for the sector.

RNL Bio, a South Korean biotech company, is venturing into the world of treating human diseases through stem cell therapies, raising the prospects of a new, highly profitable export industry.

The company, famous for the commercial cloning of dogs, is developing therapies using adult stem cells to treat degenerative diseases